PL3386489T3 - Miękkie kapsułki żelatynowe o uwalnianiu niezależnym od pH - Google Patents
Miękkie kapsułki żelatynowe o uwalnianiu niezależnym od pHInfo
- Publication number
- PL3386489T3 PL3386489T3 PL16809301.1T PL16809301T PL3386489T3 PL 3386489 T3 PL3386489 T3 PL 3386489T3 PL 16809301 T PL16809301 T PL 16809301T PL 3386489 T3 PL3386489 T3 PL 3386489T3
- Authority
- PL
- Poland
- Prior art keywords
- gelatin capsules
- soft gelatin
- independent release
- independent
- release
- Prior art date
Links
- 239000007903 gelatin capsule Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITUB2015A006821A ITUB20156821A1 (it) | 2015-12-09 | 2015-12-09 | CAPSULE DI GELATINA MOLLE A RILASCIO pH INDIPENDENTE |
| PCT/EP2016/078913 WO2017097612A1 (en) | 2015-12-09 | 2016-11-25 | SOFT GELATIN CAPSULES WITH pH-INDEPENDENT RELEASE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3386489T3 true PL3386489T3 (pl) | 2025-01-20 |
Family
ID=55588401
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16809301.1T PL3386489T3 (pl) | 2015-12-09 | 2016-11-25 | Miękkie kapsułki żelatynowe o uwalnianiu niezależnym od pH |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11304910B2 (pl) |
| EP (1) | EP3386489B1 (pl) |
| CN (1) | CN108366971A (pl) |
| CY (1) | CY1127364T1 (pl) |
| DK (1) | DK3386489T3 (pl) |
| ES (1) | ES2990251T3 (pl) |
| HK (1) | HK1255969A1 (pl) |
| HU (1) | HUE069612T2 (pl) |
| IT (1) | ITUB20156821A1 (pl) |
| PL (1) | PL3386489T3 (pl) |
| RU (1) | RU2738933C2 (pl) |
| SI (1) | SI3386489T1 (pl) |
| WO (1) | WO2017097612A1 (pl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3311844A1 (en) | 2016-10-18 | 2018-04-25 | Altergon S.A. | High-stability packaged solutions of t4 thyroid hormone |
| CN108938588B (zh) * | 2018-08-16 | 2021-06-22 | 广州维奥康药业科技有限公司 | 一种依折麦布片 |
| US11241382B2 (en) | 2019-03-01 | 2022-02-08 | Altergon Sa | Administration regimen of compositions of T4 thyroid hormone with high oral absorption |
| JP7628537B2 (ja) * | 2019-10-28 | 2025-02-10 | アール.ピー.シェーラー テクノロジーズ,エルエルシー | より高いph環境における遅延放出ソフトゲルカプセル |
| CN112826807B (zh) * | 2021-01-29 | 2022-10-04 | 北京航洋健康科技有限公司 | 一种软胶囊囊壳及由其制备的软胶囊及其制备方法 |
| WO2023167803A1 (en) * | 2022-03-01 | 2023-09-07 | Sittner Edward Oscar | Method of manufacture of active ingredient infused gelatin capsule |
| IT202300020130A1 (it) | 2023-09-29 | 2025-03-29 | Ibsa Inst Biochimique Sa | Formulazioni farmaceutiche stabili di amminoacidi, peptidi o proteine |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8305693D0 (en) * | 1983-03-02 | 1983-04-07 | Scherer Ltd R P | Pharmaceutical compositions |
| US4795642A (en) * | 1986-05-01 | 1989-01-03 | Pharmacaps, Inc. | Gelatin-encapsulated controlled-release composition |
| US4708834A (en) * | 1986-05-01 | 1987-11-24 | Pharmacaps, Inc. | Preparation of gelatin-encapsulated controlled release composition |
| US5102666A (en) * | 1990-09-11 | 1992-04-07 | Oramed, Inc. | Calcium polycarbophil controlled release composition and method |
| WO1995011668A1 (en) * | 1993-10-29 | 1995-05-04 | Reckitt & Colman Products Limited | Gelatin capsule fill able to foam |
| CA2308291A1 (en) * | 1997-10-31 | 1999-05-14 | Thierry Nivaggioli | Controlled release compositions comprising gellan gum gels |
| EP1184033A1 (en) * | 2000-09-01 | 2002-03-06 | Warner-Lambert Company | Pectin film compositions |
| ITMI20011401A1 (it) * | 2001-07-02 | 2003-01-02 | Altergon Sa | Formulazioni farmaceutiche per ormoni tiroidei |
| US20070098784A1 (en) * | 2001-09-28 | 2007-05-03 | Nutraceutix, Inc. | Delivery system for biological component |
| GB0210397D0 (en) * | 2002-05-07 | 2002-06-12 | Ferring Bv | Pharmaceutical formulations |
| CN100335134C (zh) * | 2005-10-26 | 2007-09-05 | 中国药科大学 | 尼莫地平软胶囊及其制备方法 |
| US20070148248A1 (en) * | 2005-12-22 | 2007-06-28 | Banner Pharmacaps, Inc. | Gastric reflux resistant dosage forms |
| US20080107779A1 (en) * | 2006-11-06 | 2008-05-08 | Sara Lee Corporation | Pancrepe and method of making same |
| CA2706368A1 (en) * | 2007-11-20 | 2009-05-28 | Cadbury Adams Usa Llc | Dual coated confectionery product |
| WO2009126742A2 (en) * | 2008-04-08 | 2009-10-15 | Appian Labs, Llc | Enzyme mediated delivery system |
| KR20090131256A (ko) * | 2008-06-17 | 2009-12-28 | 주식회사파마펙스 | 함습 억제 및 방출속도 조절을 위한 생약추출물 함유 서방성 제제 |
| CN102342963B (zh) * | 2011-10-19 | 2013-07-10 | 西安大唐制药集团有限公司 | 一种肝苏软胶囊的制备工艺 |
| CN103860732A (zh) * | 2014-04-10 | 2014-06-18 | 西安大唐制药集团有限公司 | 一种复方益肝灵软胶囊的制备方法 |
-
2015
- 2015-12-09 IT ITUB2015A006821A patent/ITUB20156821A1/it unknown
-
2016
- 2016-11-25 DK DK16809301.1T patent/DK3386489T3/da active
- 2016-11-25 HU HUE16809301A patent/HUE069612T2/hu unknown
- 2016-11-25 RU RU2018120693A patent/RU2738933C2/ru active
- 2016-11-25 SI SI201631862T patent/SI3386489T1/sl unknown
- 2016-11-25 ES ES16809301T patent/ES2990251T3/es active Active
- 2016-11-25 HK HK18115043.5A patent/HK1255969A1/zh unknown
- 2016-11-25 US US15/781,708 patent/US11304910B2/en active Active
- 2016-11-25 CN CN201680071964.2A patent/CN108366971A/zh active Pending
- 2016-11-25 WO PCT/EP2016/078913 patent/WO2017097612A1/en not_active Ceased
- 2016-11-25 EP EP16809301.1A patent/EP3386489B1/en active Active
- 2016-11-25 PL PL16809301.1T patent/PL3386489T3/pl unknown
-
2024
- 2024-10-15 CY CY20241100733T patent/CY1127364T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1255969A1 (zh) | 2019-09-06 |
| RU2018120693A (ru) | 2020-01-10 |
| CA3007592A1 (en) | 2017-06-15 |
| DK3386489T3 (da) | 2024-09-23 |
| US11304910B2 (en) | 2022-04-19 |
| WO2017097612A1 (en) | 2017-06-15 |
| CN108366971A (zh) | 2018-08-03 |
| ITUB20156821A1 (it) | 2017-06-09 |
| RU2738933C2 (ru) | 2020-12-18 |
| CY1127364T1 (el) | 2026-02-25 |
| EP3386489A1 (en) | 2018-10-17 |
| ES2990251T3 (es) | 2024-11-29 |
| SI3386489T1 (sl) | 2025-01-31 |
| US20180353432A1 (en) | 2018-12-13 |
| RU2018120693A3 (pl) | 2020-03-04 |
| HUE069612T2 (hu) | 2025-03-28 |
| EP3386489B1 (en) | 2024-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201708561B (en) | Microcapsules | |
| AU365267S (en) | Ring | |
| TWD174458S (zh) | 戒指 | |
| ZA201703444B (en) | Calcifediol soft capsules | |
| GB201417067D0 (en) | Radiopharmaceutical conjugate | |
| GB201603511D0 (en) | Perfusion phantom | |
| GB201608157D0 (en) | Capsules | |
| HUE069612T2 (hu) | pH-tól független felszabadulású puha zselatinkapszulák | |
| IL266022A (en) | Capsule with controlled release | |
| SG11201701972PA (en) | Soft capsule shell | |
| SG10201605127UA (en) | Theater seating | |
| SI3145497T1 (sl) | Obložene kapsule s prirejenim sproščanjem | |
| GB2547028B (en) | Early connection release | |
| SI3145499T1 (sl) | Obložene kapsule s prirejenim sproščanjem | |
| SG11201800516TA (en) | Enteric capsule | |
| IL259959A (en) | Oxygen-generating capsule | |
| ZA201800184B (en) | Extended release capecitabine capsules | |
| IL273766A (en) | dose capsule | |
| GB201716001D0 (en) | EG tipex etc capsules | |
| GB201509538D0 (en) | Hellum capsules | |
| GB201517042D0 (en) | T Shells | |
| AU201613163S (en) | Ring | |
| AU362816S (en) | Capsule | |
| GB201517946D0 (en) | Softgel | |
| GB201512525D0 (en) | Candle capsule |